Soy isoflavones ehance artery function in stroke patients

3 November 2008

A new study examines how a certain naturally-occurring component of soy may enhance the function of arteries in stroke patients.

Published recently in the European Heart Journal by researchers at the University of Hong Kong, the evaluation found that a diet rich in soy beans and soy isoflavones boosts artery health. Isoflavones are natural compounds found in soy that, although different from the hormone estrogen, do exert a mild estrogen-like effect under certain conditions.

The researchers recruited 102 stroke patients, randomly assigned daily intake of 80mg soy isoflavones supplements to 50 patients and gave a placebo to the remainder for 12 weeks. The study found that the participants who consumed soy isoflavones had a significant increase in flow-mediated dilation, the measure of the ability of blood vessels to relax.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight